Episode Details

The U.S. is overhauling its medical supply distribution for HIV and malaria in developing nations, terminating a key program managed by Chemonics. This program, active since 2016, delivered over $5 billion worth of drugs and bed nets to 90 countries, primarily in Africa and Asia. The change comes after President Trumps freeze on foreign aid, budget cuts, and a shift towards direct deals with governments. Critics warn this could lead to shortages, impacting patients lives. The program is set to end by May 30th, with no clear handover plan, and the State Department is pushing for bilateral agreements and private shippers.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/451bc13e415d3f75